| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase activity | NPR2 TRIO GNE MAPKAPK2 RPS6KA1 GLYCTK STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 DLG2 LYN STK38L DCLK1 DYRK3 DYRK2 | 5.49e-07 | 764 | 143 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NPR2 TRIO GNE MAPKAPK2 RPS6KA1 GLYCTK STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 7.64e-07 | 709 | 143 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | NPR2 TRIO GNE MAPKAPK2 POLD1 RPS6KA1 GLYCTK STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 DLG2 POLR1B LYN STK38L DCLK1 DYRK3 DYRK2 | 8.97e-07 | 938 | 143 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | NPR2 TRIO MAPKAPK2 RPS6KA1 STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 1.45e-06 | 600 | 143 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRIO MAPKAPK2 RPS6KA1 STK38 MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 2.18e-06 | 363 | 143 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRIO MAPKAPK2 RPS6KA1 STK38 MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 1.99e-05 | 446 | 143 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 8.09e-05 | 144 | 143 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 VWA8 SMCHD1 ABCB5 PEX1 CHD9 RECQL4 CHD6 KIF18B DNAH9 TAP2 HSPA7 | 8.11e-05 | 441 | 143 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.82e-05 | 103 | 143 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 CENPE VWA8 SMCHD1 ABCB5 PEX1 CHD9 RECQL4 CHD6 KIF18B DNAH9 TAP2 HSPA7 ATP6V0A2 | 1.35e-04 | 614 | 143 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 3.54e-04 | 47 | 143 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 4.14e-04 | 247 | 143 | 8 | GO:0000287 | |
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 5.02e-04 | 5 | 143 | 2 | GO:0000298 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 5.02e-04 | 5 | 143 | 2 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 5.02e-04 | 5 | 143 | 2 | GO:0008486 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 7.37e-04 | 25 | 143 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 7.50e-04 | 6 | 143 | 2 | GO:0034432 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 1.39e-03 | 8 | 143 | 2 | GO:0000405 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MPP2 TRIO MAP2 SPTAN1 STK38 ITGA8 NRXN3 TIAM1 PURA PRKACA DLG2 LYN STK38L DCLK1 CNN3 | 5.26e-04 | 817 | 144 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | leading edge membrane | 6.43e-04 | 210 | 144 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynapse | MPP2 RPL36A TRIO MAP2 SPTAN1 ITGA8 DNAJC6 IGF2BP1 TIAM1 PURA PRKACA SORCS2 DLG2 AFDN LYN DCLK1 CNN3 | 6.52e-04 | 1018 | 144 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | MPP2 MAP2 ITGA8 DNAJC6 TIAM1 PURA SORCS2 DLG2 AFDN LYN DCLK1 | 7.41e-04 | 503 | 144 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.75e-04 | 157 | 144 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | peroxisome | 9.13e-04 | 162 | 144 | 6 | GO:0005777 | |
| GeneOntologyCellularComponent | microbody | 9.13e-04 | 162 | 144 | 6 | GO:0042579 | |
| GeneOntologyCellularComponent | ruffle membrane | 9.13e-04 | 108 | 144 | 5 | GO:0032587 | |
| Domain | Kinase-like_dom | NPR2 TRIO MAPKAPK2 RPS6KA1 STK38 CHD9 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 1.29e-07 | 542 | 140 | 18 | IPR011009 |
| Domain | Prot_kinase_dom | NPR2 TRIO MAPKAPK2 RPS6KA1 STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 1.55e-07 | 489 | 140 | 17 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | NPR2 TRIO MAPKAPK2 RPS6KA1 STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 1.75e-07 | 493 | 140 | 17 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | TRIO MAPKAPK2 RPS6KA1 STK38 TEK MAP3K3 NEK2 BMX PRKACA CHEK2 SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 3.57e-07 | 459 | 140 | 16 | PS00107 |
| Domain | S_TKc | TRIO MAPKAPK2 RPS6KA1 STK38 TEK MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 5.33e-07 | 359 | 140 | 14 | SM00220 |
| Domain | Pkinase | NPR2 TRIO MAPKAPK2 RPS6KA1 STK38 MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 1.08e-06 | 381 | 140 | 14 | PF00069 |
| Domain | Ser/Thr_kinase_AS | TRIO MAPKAPK2 RPS6KA1 STK38 MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 2.95e-06 | 357 | 140 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | TRIO MAPKAPK2 RPS6KA1 STK38 MAP3K3 NEK2 PRKACA CHEK2 SIK2 STK38L DCLK1 DYRK3 DYRK2 | 3.44e-06 | 362 | 140 | 13 | PS00108 |
| Domain | Protein_kinase_ATP_BS | MAPKAPK2 RPS6KA1 STK38 TEK BMX PRKACA SIK2 LYN STK38L DCLK1 DYRK3 DYRK2 | 2.90e-05 | 379 | 140 | 12 | IPR017441 |
| Domain | Ribosomal_L44e | 5.58e-05 | 2 | 140 | 2 | IPR000552 | |
| Domain | Ribosomal_L44e | 5.58e-05 | 2 | 140 | 2 | PD002841 | |
| Domain | RIBOSOMAL_L44E | 5.58e-05 | 2 | 140 | 2 | PS01172 | |
| Domain | Ribosomal_L44 | 5.58e-05 | 2 | 140 | 2 | PF00935 | |
| Domain | - | 5.58e-05 | 2 | 140 | 2 | 3.10.450.80 | |
| Domain | TF_octamer | 1.67e-04 | 3 | 140 | 2 | IPR000972 | |
| Domain | Pkinase_C | 2.71e-04 | 42 | 140 | 4 | PF00433 | |
| Domain | Spectrin | 6.54e-04 | 23 | 140 | 3 | PF00435 | |
| Domain | BRK | 8.20e-04 | 6 | 140 | 2 | SM00592 | |
| Domain | BRK_domain | 8.20e-04 | 6 | 140 | 2 | IPR006576 | |
| Domain | EFhand_Ca_insen | 8.20e-04 | 6 | 140 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 8.20e-04 | 6 | 140 | 2 | IPR014837 | |
| Domain | BRK | 8.20e-04 | 6 | 140 | 2 | PF07533 | |
| Domain | AGC-kinase_C | 8.21e-04 | 56 | 140 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 8.21e-04 | 56 | 140 | 4 | PS51285 | |
| Domain | S_TK_X | 8.21e-04 | 56 | 140 | 4 | SM00133 | |
| Domain | - | 1.06e-03 | 27 | 140 | 3 | 1.10.260.40 | |
| Domain | SH3 | 1.23e-03 | 216 | 140 | 7 | SM00326 | |
| Domain | SH3 | 1.23e-03 | 216 | 140 | 7 | PS50002 | |
| Domain | Lambda_DNA-bd_dom | 1.31e-03 | 29 | 140 | 3 | IPR010982 | |
| Domain | Spectrin_repeat | 1.31e-03 | 29 | 140 | 3 | IPR002017 | |
| Domain | SH3_domain | 1.37e-03 | 220 | 140 | 7 | IPR001452 | |
| Domain | SH3_1 | 1.49e-03 | 164 | 140 | 6 | PF00018 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RPL36AL RPL36A TRIO MAPKAPK2 RPS6KA1 STK38 PEX1 ACOX3 MAP3K3 NEK2 RNF2 PIK3R2 PURA CHEK2 SIK2 LYN STK38L DYRK2 | 4.65e-08 | 910 | 144 | 18 | 36736316 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 HEXB GBF1 RPL36A ACACA POLD1 SPTAN1 STK38 LARP1 IGF2BP1 IGF2BP3 PDRG1 BTF3 RRP12 PRKACA AFDN STK38L NMT1 IQGAP3 CNN3 | 6.37e-08 | 1149 | 144 | 20 | 35446349 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 ACACA TRIO MAP2 SPTAN1 NELFB LARP1 ANKRD27 MAP3K3 BMX ALMS1 TIAM1 SIK2 AFDN PLCH1 DCLK1 DYRK2 | 1.16e-07 | 861 | 144 | 17 | 36931259 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 RPL36AL RPL36A ACACA POLD1 SMCHD1 AHCTF1 USP24 LARP1 SUCLG2 ANKRD27 SNRPGP15 IGF2BP1 IGF2BP3 BTF3 RBMX2 RRP12 MRPS11 POLR1B CHD6 LYN | 1.27e-07 | 1318 | 144 | 21 | 30463901 |
| Pubmed | SIN3B ACACA SMCHD1 AHCTF1 SPTAN1 USP24 LARP1 MIDEAS RNF2 ALMS1 AFDN CNN3 RGPD5 | 5.26e-07 | 549 | 144 | 13 | 38280479 | |
| Pubmed | 6.91e-07 | 5 | 144 | 3 | 3027087 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | ACACA SPTAN1 USP24 STK38 IGF2BP1 PIK3R2 POLR1B AFDN STK38L HSPA7 | 8.98e-07 | 317 | 144 | 10 | 17620599 |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.32e-06 | 256 | 144 | 9 | 32698014 | |
| Pubmed | HSPD1 RPL36AL RPL36A STK38 PEX1 LARP1 CHD9 SNRPGP15 IGF2BP1 IGF2BP3 RNF2 PURA MRPS11 CHD6 LYN STK38L MRPL11 HSPA7 | 1.46e-06 | 1153 | 144 | 18 | 29845934 | |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.62e-06 | 86 | 144 | 6 | 10862698 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 SIN3B RPL36A ACACA SMCHD1 AHCTF1 LARP1 IGF2BP1 IARS2 IGF2BP3 RBM12 ALMS1 BTF3 RRP12 NMT1 CNN3 | 1.80e-06 | 934 | 144 | 16 | 33916271 |
| Pubmed | HSPD1 HEXB MPP2 TRIO MAP2 NAT9 PRXL2B SPTA1 SPTAN1 LARP1 DNAJC6 ZC2HC1A CRACDL PURA PRKACA SORCS2 DLG2 AFDN PLCH1 DCLK1 | 1.99e-06 | 1431 | 144 | 20 | 37142655 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.16e-06 | 202 | 144 | 8 | 33005030 | |
| Pubmed | HSPD1 CUX2 RPL36AL RPL36A PCDHGA1 SMCHD1 SPTA1 ABCB5 SPTAN1 LARP1 NEK2 NRXN3 RNF2 RBMX2 PRKACA DLG2 CHD6 PLCH1 MRPL11 RGPD5 | 2.23e-06 | 1442 | 144 | 20 | 35575683 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 RPL36AL RPL36A MAP2 VWA8 SPTAN1 STK38 CHD9 TRIM71 IGF2BP1 IGF2BP3 ZC2HC1A RBMX2 RRP12 MRPS11 CHD6 SLC25A19 | 2.69e-06 | 1082 | 144 | 17 | 38697112 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | TRMT1 LARP1 TRIM71 IGF2BP3 ALMS1 PIK3R2 PURA RRP12 RECQL4 IQGAP3 | 3.09e-06 | 364 | 144 | 10 | 24778252 |
| Pubmed | HSPD1 RPL36A MAP2 VWA8 SYNM POLD1 AHCTF1 SPTAN1 DNAJC6 DNAJB13 IARS2 TIAM1 PIK3R2 RRP12 PRKACA MRPS11 EFR3B SIK2 PLCH1 ATP6V0A2 | 3.54e-06 | 1487 | 144 | 20 | 33957083 | |
| Pubmed | 3.83e-06 | 8 | 144 | 3 | 11551945 | ||
| Pubmed | ACOT8 GBF1 SPOUT1 VWA8 SMCHD1 AHCTF1 SPTAN1 LARP1 TRIM71 SUCLG2 MIDEAS SNRPGP15 IGF2BP1 IGF2BP3 RNF2 RBMX2 PURA SLC25A19 NMT1 | 4.15e-06 | 1371 | 144 | 19 | 36244648 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | HSPD1 IGF2BP1 IGF2BP3 PIK3R2 RBMX2 PURA RRP12 RECQL4 NMT1 IQGAP3 HSPA7 | 6.25e-06 | 486 | 144 | 11 | 30940648 |
| Pubmed | HSPD1 SIN3B RPL36AL RPL36A SMCHD1 SPTAN1 LARP1 POU2F1 MIDEAS IGF2BP1 IGF2BP3 RBM12 RNF2 ALMS1 PURA RRP12 MRPS11 CHD6 MRPL11 | 7.48e-06 | 1429 | 144 | 19 | 35140242 | |
| Pubmed | HSPD1 RPL36A VWA8 VAMP5 POLD1 SPTAN1 LARP1 ARHGAP11A SUCLG2 IGF2BP1 IARS2 IGF2BP3 BTF3 PURA RRP12 MRPS11 LTF MRPL11 TAP2 | 8.33e-06 | 1440 | 144 | 19 | 30833792 | |
| Pubmed | HSPD1 AHCTF1 USP24 NELFB TRMT1 LARP1 IGF2BP1 ZC2HC1A RRP12 AFDN NMT1 | 8.63e-06 | 503 | 144 | 11 | 16964243 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SIN3B SMCHD1 AHCTF1 NELFB POU2F1 CHD9 ARHGAP11A MIDEAS RNF2 RBMX2 CHD6 KIF18B | 9.34e-06 | 608 | 144 | 12 | 36089195 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSPD1 RPL36AL RPL36A SPOUT1 AHCTF1 SPTAN1 LARP1 IGF2BP1 IGF2BP3 BTF3 RBMX2 RRP12 POLR1B LTF HSPA7 | 1.01e-05 | 949 | 144 | 15 | 36574265 |
| Pubmed | RPL36AL RPL36A USP24 NELFB LARP1 MIDEAS IGF2BP1 RNF2 PDRG1 BTF3 RRP12 RECQL4 | 1.05e-05 | 615 | 144 | 12 | 31048545 | |
| Pubmed | 1.19e-05 | 255 | 144 | 8 | 15324660 | ||
| Pubmed | HSPD1 RPL36AL RPL36A POLD1 SPTAN1 SUCLG2 IGF2BP1 IGF2BP3 PURA MRPL11 | 1.20e-05 | 425 | 144 | 10 | 21081503 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.30e-05 | 258 | 144 | 8 | 37794589 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 ACACA SPOUT1 GNE POLD1 SMCHD1 AHCTF1 SPTAN1 SUCLG2 MIDEAS ANKRD27 ZC2HC1A RRP12 RECQL4 POLR1B AFDN LTF KIF18B | 1.32e-05 | 1353 | 144 | 18 | 29467282 |
| Pubmed | SIN3B ACOT8 RPL36AL POLD1 AHCTF1 RNF2 BTF3 RBMX2 CRACDL PURA RRP12 PRKACA POLR1B AFDN CHD6 NMT1 IQGAP3 DCLK1 ATP6V0A2 | 1.43e-05 | 1497 | 144 | 19 | 31527615 | |
| Pubmed | HSPD1 ACACA VWA8 SMCHD1 SPTAN1 GLYCTK STK38 PEX1 ESYT3 IGF2BP3 CHD6 LTF WWC1 | 1.64e-05 | 754 | 144 | 13 | 35906200 | |
| Pubmed | Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. | 1.70e-05 | 2 | 144 | 2 | 12663137 | |
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 1.70e-05 | 2 | 144 | 2 | 25601544 | |
| Pubmed | Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis. | 1.70e-05 | 2 | 144 | 2 | 20501446 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12689335 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 15831936 | ||
| Pubmed | Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. | 1.70e-05 | 2 | 144 | 2 | 11583619 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31771949 | ||
| Pubmed | Identification of novel single-stranded DNA binding proteins recognizing octamer motif. | 1.70e-05 | 2 | 144 | 2 | 8185580 | |
| Pubmed | αII-spectrin regulates invadosome stability and extracellular matrix degradation. | 1.70e-05 | 2 | 144 | 2 | 25830635 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12921532 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11992722 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12105228 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 12144930 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 32721184 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 8156594 | ||
| Pubmed | The non-receptor tyrosine kinase Lyn is localised in the developing murine blood-brain barrier. | 1.70e-05 | 2 | 144 | 2 | 7589891 | |
| Pubmed | The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain. | 1.70e-05 | 2 | 144 | 2 | 8262198 | |
| Pubmed | Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. | 1.70e-05 | 2 | 144 | 2 | 1684878 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 15037617 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 1.70e-05 | 2 | 144 | 2 | 16541107 | |
| Pubmed | RPS6KA1 PEX1 LARP1 MIB2 ANKRD27 RECQL4 SIK2 AFDN PLCH1 NMT1 IQGAP3 RIC1 | 1.81e-05 | 650 | 144 | 12 | 38777146 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 SPOUT1 SYNM SMCHD1 AHCTF1 SPTAN1 LARP1 ARHGAP11A IARS2 BTF3 RRP12 POLR1B LTF LYN NMT1 MRPL11 IQGAP3 | 1.89e-05 | 1257 | 144 | 17 | 36526897 |
| Pubmed | 1.93e-05 | 13 | 144 | 3 | 25574476 | ||
| Pubmed | 2.07e-05 | 39 | 144 | 4 | 1676977 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ACOT8 POLD1 LARP1 MIB2 SUCLG2 IGF2BP1 IGF2BP3 DLG2 SLC25A19 DYRK2 | 2.44e-05 | 462 | 144 | 10 | 31138677 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 HEXB GBF1 ACACA GNE MAP2 POLD1 RPS6KA1 SPTAN1 USP24 NELFB TRMT1 LARP1 IGF2BP3 RBM12 BTF3 PRKACA NMT1 | 3.43e-05 | 1455 | 144 | 18 | 22863883 |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 3.89e-05 | 220 | 144 | 7 | 31822558 | |
| Pubmed | HSPD1 GBF1 SMCHD1 AHCTF1 SPTAN1 LARP1 SNRPGP15 IGF2BP1 IGF2BP3 AFDN LTF NMT1 | 4.32e-05 | 711 | 144 | 12 | 33022573 | |
| Pubmed | 4.48e-05 | 225 | 144 | 7 | 12168954 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ACOT8 MAP2 SMCHD1 AHCTF1 USP24 LARP1 IGF2BP1 IGF2BP3 RRP12 CNN3 | 4.60e-05 | 498 | 144 | 10 | 36634849 |
| Pubmed | ACOT8 ACACA VWA8 POLD1 PEX1 ANKRD27 IARS2 RRP12 POLR1B SLC25A19 IQGAP3 | 4.75e-05 | 606 | 144 | 11 | 36538041 | |
| Pubmed | RPL36AL SPOUT1 SMCHD1 LARP1 IGF2BP1 IGF2BP3 RBM12 BTF3 MRPS11 KIF18B NMT1 CNN3 | 5.07e-05 | 723 | 144 | 12 | 34133714 | |
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 5.09e-05 | 3 | 144 | 2 | 17296566 | |
| Pubmed | Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability. | 5.09e-05 | 3 | 144 | 2 | 21262772 | |
| Pubmed | The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. | 5.09e-05 | 3 | 144 | 2 | 2905684 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11594778 | ||
| Pubmed | Cross-talk between protein kinase A and the MAPK-activated protein kinases RSK1 and MK5. | 5.09e-05 | 3 | 144 | 2 | 20849292 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 33692755 | ||
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 5.09e-05 | 3 | 144 | 2 | 29476152 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23897809 | ||
| Pubmed | Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. | 5.09e-05 | 3 | 144 | 2 | 8622679 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 10490647 | ||
| Pubmed | Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. | 5.09e-05 | 3 | 144 | 2 | 9584182 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17442950 | ||
| Pubmed | Phosphorylation of the stress-activated protein kinase, MEKK3, at serine 166. | 5.09e-05 | 3 | 144 | 2 | 12392720 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22879911 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9823775 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 14729950 | ||
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 5.09e-05 | 3 | 144 | 2 | 32668274 | |
| Pubmed | OBF1 and Oct factors control the germinal center transcriptional program. | 5.09e-05 | 3 | 144 | 2 | 33512466 | |
| Pubmed | Interaction domains of neurofilament light chain and brain spectrin. | 5.09e-05 | 3 | 144 | 2 | 1902666 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 1545828 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 3542712 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 38254723 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11029056 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20627640 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9724719 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 10734119 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 19710692 | ||
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 5.09e-05 | 3 | 144 | 2 | 16049158 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9891060 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12213813 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 32134323 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 5.09e-05 | 3 | 144 | 2 | 2971657 | |
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 5.09e-05 | 3 | 144 | 2 | 15601260 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 12121577 | ||
| Pubmed | The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. | 5.09e-05 | 3 | 144 | 2 | 8202368 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20080952 | ||
| Interaction | DTNA interactions | 2.63e-06 | 125 | 140 | 8 | int:DTNA | |
| Interaction | YBX1 interactions | HSPD1 RPL36AL GBF1 MAP2 RPS6KA1 NELFB LARP1 TRIM71 IGF2BP1 IGF2BP3 RNF2 BTF3 PURA RECQL4 MRPS11 NEIL3 NMT1 MRPL11 | 4.81e-06 | 752 | 140 | 18 | int:YBX1 |
| Interaction | SKAP1 interactions | 7.16e-06 | 102 | 140 | 7 | int:SKAP1 | |
| Interaction | D2HGDH interactions | 8.35e-06 | 146 | 140 | 8 | int:D2HGDH | |
| Interaction | YWHAE interactions | GBF1 CENPE SPTAN1 NELFB LARP1 COL6A5 ANKRD27 MAP3K3 IGF2BP1 IARS2 IGF2BP3 TIAM1 PIK3R2 BTF3 PURA RECQL4 PRKACA SIK2 AFDN PLCH1 STK38L DCLK1 WWC1 | 1.80e-05 | 1256 | 140 | 23 | int:YWHAE |
| Interaction | YWHAB interactions | GBF1 MAP2 CENPE POLD1 RPS6KA1 SPTAN1 NELFB STK38 LARP1 MAP3K3 TIAM1 PIK3R2 BTF3 RECQL4 SIK2 AFDN PLCH1 STK38L DCLK1 WWC1 | 2.38e-05 | 1014 | 140 | 20 | int:YWHAB |
| Interaction | GSK3B interactions | HSPD1 RPL36AL ACACA TRIO VWA8 NAT9 RPS6KA1 IGF2BP1 IARS2 IGF2BP3 ALMS1 BTF3 RECQL4 PRKACA CHD6 LTF WWC1 DYRK2 | 3.31e-05 | 868 | 140 | 18 | int:GSK3B |
| Interaction | H1-4 interactions | RPL36AL ITGA8 LARP1 TRIM71 IGF2BP1 IGF2BP3 RNF2 BTF3 RBMX2 PURA RRP12 RECQL4 MTHFD2L LYN NMT1 | 5.29e-05 | 656 | 140 | 15 | int:H1-4 |
| Interaction | RBM28 interactions | RPL36AL SPOUT1 POLD1 STK38 TRMT1 TEK RNF2 RBMX2 RRP12 CHEK2 LYN | 5.38e-05 | 368 | 140 | 11 | int:RBM28 |
| Interaction | CDCA5 interactions | 5.59e-05 | 140 | 140 | 7 | int:CDCA5 | |
| Interaction | DHX9 interactions | MAN2C1 MAP2 POLD1 SPTAN1 NELFB TRIM71 IGF2BP1 IGF2BP3 RNF2 BTF3 RBMX2 RECQL4 CHEK2 NEIL3 NMT1 | 5.86e-05 | 662 | 140 | 15 | int:DHX9 |
| Interaction | MAPRE1 interactions | TRIO MAP2 CENPE SPTAN1 LARP1 DNAJC6 MEOX2 ZC2HC1A ALMS1 PRKACA KIF18B CNN3 RGPD5 | 6.25e-05 | 514 | 140 | 13 | int:MAPRE1 |
| Interaction | DCAF5 interactions | 6.29e-05 | 98 | 140 | 6 | int:DCAF5 | |
| Interaction | PAGE4 interactions | 7.05e-05 | 253 | 140 | 9 | int:PAGE4 | |
| Interaction | MYH9 interactions | HSPD1 GBF1 ACACA SPTAN1 CHD9 ARHGAP11A MIDEAS NEK2 IARS2 PIK3R2 BTF3 PRKACA SIK2 LYN STK38L CNN3 | 7.14e-05 | 754 | 140 | 16 | int:MYH9 |
| Interaction | WDR5 interactions | HSPD1 GBF1 ACACA SMCHD1 AHCTF1 SPTAN1 LARP1 MEOX2 SNRPGP15 IGF2BP1 IGF2BP3 RNF2 ZC2HC1A BTF3 RECQL4 AFDN LTF NMT1 MRPL11 DYRK2 | 7.53e-05 | 1101 | 140 | 20 | int:WDR5 |
| Interaction | YWHAH interactions | GBF1 TRIO MAP2 RPS6KA1 SPTAN1 NELFB LARP1 ANKRD27 MAP3K3 IARS2 ALMS1 TIAM1 BTF3 PURA RECQL4 SIK2 AFDN PLCH1 DCLK1 WWC1 | 7.63e-05 | 1102 | 140 | 20 | int:YWHAH |
| Interaction | RBM47 interactions | 9.16e-05 | 204 | 140 | 8 | int:RBM47 | |
| Interaction | LRRC31 interactions | 9.48e-05 | 205 | 140 | 8 | int:LRRC31 | |
| Interaction | GRIN1 interactions | 1.02e-04 | 154 | 140 | 7 | int:GRIN1 | |
| Interaction | MRPS25 interactions | 1.12e-04 | 269 | 140 | 9 | int:MRPS25 | |
| Interaction | HOXB5 interactions | 1.32e-04 | 112 | 140 | 6 | int:HOXB5 | |
| Interaction | TULP2 interactions | 1.52e-04 | 39 | 140 | 4 | int:TULP2 | |
| Interaction | MIR29B1 interactions | 1.55e-04 | 73 | 140 | 5 | int:MIR29B1 | |
| Interaction | NMT1 interactions | 1.57e-04 | 165 | 140 | 7 | int:NMT1 | |
| Interaction | CAV1 interactions | GBF1 TRIO SPTAN1 STK38 TEK BMX TIAM1 PIK3R2 RRP12 PRKACA EFR3B AFDN LYN RIC1 ATP6V0A2 | 1.58e-04 | 724 | 140 | 15 | int:CAV1 |
| Interaction | CBX6 interactions | 1.65e-04 | 283 | 140 | 9 | int:CBX6 | |
| Interaction | FANCA interactions | 1.69e-04 | 167 | 140 | 7 | int:FANCA | |
| Interaction | PURG interactions | 1.69e-04 | 223 | 140 | 8 | int:PURG | |
| Interaction | HSP90AA1 interactions | TRIM2 EEF1AKMT3 RPS6KA1 SPTAN1 STK38 POU2F1 MAP3K3 IARS2 IGF2BP3 BMX PDRG1 SLC34A1 PIK3R2 BTF3 RECQL4 PRKACA NEIL3 LYN STK38L HSPA7 DYRK2 | 1.70e-04 | 1263 | 140 | 21 | int:HSP90AA1 |
| Interaction | GUSBP5 interactions | 1.76e-04 | 75 | 140 | 5 | int:GUSBP5 | |
| Interaction | PLK3 interactions | 1.85e-04 | 41 | 140 | 4 | int:PLK3 | |
| Interaction | ZC3H3 interactions | 1.86e-04 | 226 | 140 | 8 | int:ZC3H3 | |
| Interaction | GRIN2B interactions | 1.88e-04 | 170 | 140 | 7 | int:GRIN2B | |
| Interaction | MAST1 interactions | 1.97e-04 | 228 | 140 | 8 | int:MAST1 | |
| Interaction | LIMA1 interactions | 2.07e-04 | 429 | 140 | 11 | int:LIMA1 | |
| Interaction | MAPRE3 interactions | 2.09e-04 | 230 | 140 | 8 | int:MAPRE3 | |
| Interaction | ABCE1 interactions | HEXB SPOUT1 TRMT1 SUCLG2 BMX RNF2 RRP12 PRKACA MTHFD2L POLR1B LYN | 2.16e-04 | 431 | 140 | 11 | int:ABCE1 |
| Interaction | MECP2 interactions | HSPD1 SIN3B RPL36AL RPL36A SPOUT1 MAP2 VWA8 SPTAN1 STK38 CHD9 TRIM71 IGF2BP1 IGF2BP3 ZC2HC1A BTF3 RBMX2 PURA RRP12 MRPS11 CHD6 SLC25A19 | 2.20e-04 | 1287 | 140 | 21 | int:MECP2 |
| Interaction | EEF1AKMT3 interactions | HSPD1 EEF1AKMT3 POLD1 SMCHD1 PEX1 ANKRD27 SBF2 CHEK2 HSPA7 RGPD5 | 2.34e-04 | 364 | 140 | 10 | int:EEF1AKMT3 |
| Interaction | MRPS6 interactions | 2.41e-04 | 177 | 140 | 7 | int:MRPS6 | |
| Interaction | MOV10 interactions | HSPD1 COL7A1 NPR2 ACACA MAPKAPK2 AHCTF1 STK38 LARP1 TRIM71 IGF2BP1 IGF2BP3 RBM12 RNF2 PIK3R2 RECQL4 PRKACA KIF18B SLC25A19 MRPL11 WWC1 DYRK2 | 2.44e-04 | 1297 | 140 | 21 | int:MOV10 |
| Interaction | LZTS2 interactions | HSPD1 SYNM SPTAN1 GLYCTK IARS2 BMX ALMS1 RECQL4 AFDN PLCH1 LYN DYRK2 | 2.44e-04 | 512 | 140 | 12 | int:LZTS2 |
| Interaction | MRPS11 interactions | 2.56e-04 | 237 | 140 | 8 | int:MRPS11 | |
| Interaction | LARP7 interactions | HSPD1 RPL36AL RPL36A ACACA STK38 PEX1 LARP1 CHD9 SNRPGP15 IGF2BP1 IGF2BP3 RNF2 PURA MRPS11 CHD6 LYN MRPL11 HSPA7 DYRK2 | 2.57e-04 | 1113 | 140 | 19 | int:LARP7 |
| Interaction | NR2C2 interactions | HSPD1 RPL36AL RPL36A ACACA POLD1 SMCHD1 AHCTF1 USP24 LARP1 SUCLG2 ANKRD27 SNRPGP15 IGF2BP1 IGF2BP3 BTF3 RBMX2 RRP12 MRPS11 POLR1B AFDN CHD6 LYN | 2.68e-04 | 1403 | 140 | 22 | int:NR2C2 |
| Interaction | YWHAQ interactions | GBF1 ACACA MAP2 RPS6KA1 SPTA1 NELFB LARP1 MAP3K3 IARS2 IGF2BP3 TIAM1 PIK3R2 BTF3 RECQL4 SIK2 AFDN PLCH1 DCLK1 WWC1 | 2.71e-04 | 1118 | 140 | 19 | int:YWHAQ |
| Interaction | ARRB1 interactions | 2.80e-04 | 304 | 140 | 9 | int:ARRB1 | |
| Interaction | BIN1 interactions | 2.85e-04 | 129 | 140 | 6 | int:BIN1 | |
| Interaction | BAP1 interactions | HSPD1 HEXB GBF1 RPL36A ACACA POLD1 SPTAN1 STK38 LARP1 IGF2BP1 IGF2BP3 PDRG1 BTF3 RRP12 PRKACA CHEK2 AFDN STK38L NMT1 IQGAP3 CNN3 | 2.91e-04 | 1314 | 140 | 21 | int:BAP1 |
| Interaction | CAT interactions | 2.95e-04 | 183 | 140 | 7 | int:CAT | |
| Interaction | SOCS6 interactions | 2.97e-04 | 130 | 140 | 6 | int:SOCS6 | |
| Interaction | HNRNPU interactions | GBF1 RPL36A NELFB LARP1 POU2F1 CHD9 IGF2BP1 IGF2BP3 RNF2 BTF3 SBF2 RRP12 RECQL4 CHEK2 SORCS2 MRPS11 NMT1 DYRK2 | 3.02e-04 | 1035 | 140 | 18 | int:HNRNPU |
| Interaction | EIF4E2 interactions | 3.29e-04 | 246 | 140 | 8 | int:EIF4E2 | |
| Interaction | TNIK interactions | 3.37e-04 | 381 | 140 | 10 | int:TNIK | |
| Interaction | MRPS9 interactions | HSPD1 RPL36AL ACACA VWA8 TEK IGF2BP1 IGF2BP3 RECQL4 MRPS11 MRPL11 | 3.44e-04 | 382 | 140 | 10 | int:MRPS9 |
| GeneFamily | EF-hand domain containing|Spectrins | 6.00e-04 | 7 | 98 | 2 | 1113 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.55e-03 | 11 | 98 | 2 | 1156 | |
| GeneFamily | ATP binding cassette subfamily B | 1.55e-03 | 11 | 98 | 2 | 806 | |
| Coexpression | FISCHER_DREAM_TARGETS | HSPD1 ACACA CENPE POLD1 SMCHD1 AHCTF1 POU2F1 ARHGAP11A NEK2 RNF2 ALMS1 RECQL4 CHEK2 NEIL3 KIF18B SLC25A19 IQGAP3 TCTN2 | 7.15e-06 | 969 | 145 | 18 | M149 |
| Coexpression | BENPORATH_NANOG_TARGETS | SIN3B COL7A1 ACOT8 GBF1 MAN2C1 PEX1 POU2F1 ARHGAP11A LRIG3 IGF2BP3 RNF2 ZC2HC1A TIAM1 PIK3R2 NMT1 PRDM14 CNN3 KLHL4 | 9.30e-06 | 988 | 145 | 18 | M6616 |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 1.57e-05 | 199 | 145 | 8 | M8371 | |
| Coexpression | GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.63e-05 | 200 | 145 | 8 | M8384 | |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP | 2.39e-05 | 211 | 145 | 8 | M2230 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP | 3.16e-05 | 160 | 145 | 7 | M7726 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_UP | 5.14e-05 | 235 | 145 | 8 | M6122 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | HSPD1 CENPE VAMP5 ASAH2 SPTA1 TEK IGF2BP1 IGF2BP3 ALMS1 CHEK2 NEIL3 KIF18B KLHL4 | 5.51e-06 | 423 | 142 | 13 | GSM791126_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | CUX2 TRIM2 ITGA8 LARP1 NCKAP5 ARHGAP11A MEOX2 LRIG3 NEK2 ALMS1 RBMX2 NUDT10 MTHFD2L POLR1B NEIL3 PLCH1 SLC25A19 | 1.11e-05 | 749 | 142 | 17 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | NPR2 CUX2 ITGA8 LARP1 SUCLG2 MYORG MEOX2 LRIG3 NUDT10 MTHFD2L POLR1B NEIL3 PLCH1 SLC25A19 DYRK3 | 2.56e-05 | 639 | 142 | 15 | gudmap_kidney_P0_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | CUX2 TRIM2 ITGA8 MYORG MEOX2 LRIG3 NUDT10 NEIL3 PLCH1 SLC25A19 | 2.71e-05 | 291 | 142 | 10 | gudmap_kidney_P2_CapMes_Crym_500 |
| CoexpressionAtlas | kidney_e15.5_SmlBldVes_Tie2_top-relative-expression-ranked_100 | 2.78e-05 | 88 | 142 | 6 | gudmap_kidney_e15.5_SmlBldVes_Tie2_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | COL7A1 CUX2 TRIM2 MAP2 CENPE SPTAN1 PEX1 CHD9 ARMCX4 MYORG NEK2 IGF2BP1 RBM12 ALMS1 OSGEPL1 RBMX2 RECQL4 EFR3B MTHFD2L KIF18B PLCH1 DCLK1 DYRK3 | 3.92e-05 | 1370 | 142 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | HSPD1 CENPE VAMP5 ARMCX4 TEK IGF2BP1 IGF2BP3 CHEK2 NEIL3 CNN3 KLHL4 | 1.01e-04 | 410 | 142 | 11 | GSM791122_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | HSPD1 CENPE SPTA1 ARHGAP11A NEK2 IGF2BP1 IGF2BP3 CHEK2 NEIL3 KIF18B CNN3 | 1.22e-04 | 419 | 142 | 11 | GSM538348_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.80e-04 | 123 | 142 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_200 | 2.06e-04 | 179 | 142 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_200 | |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | CENPE POU2F2 ARHGAP11A NEK2 IGF2BP3 SBF2 NEIL3 KIF18B LYN CNN3 | 2.07e-04 | 372 | 142 | 10 | GSM538204_500 |
| CoexpressionAtlas | kidney_e10.5_UretericTrunk_HoxB7_top-relative-expression-ranked_100 | 2.12e-04 | 81 | 142 | 5 | gudmap_kidney_e10.5_UretericTrunk_HoxB7_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_200 | 2.28e-04 | 182 | 142 | 7 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_200 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_500 | CUX2 ARHGAP11A TEK IGF2BP1 NUDT11 ALMS1 NUDT10 CHEK2 PLCH1 KLHL4 | 2.67e-04 | 384 | 142 | 10 | gudmap_kidney_e10.5_UretericTip_HoxB7_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HSPD1 MAP2 CENPE SMCHD1 AHCTF1 POU2F1 CHD9 MYORG NEK2 IGF2BP1 IARS2 IGF2BP3 NUDT11 NRXN3 RNF2 ALMS1 OSGEPL1 RBMX2 RECQL4 MTHFD2L NMT1 DYRK3 | 2.75e-04 | 1459 | 142 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.83e-04 | 316 | 142 | 9 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | HSPD1 MPP2 ACACA CENPE TRIM71 IGF2BP3 RRP12 POLR1B IGSF9 PLCH1 SLC25A19 LYN PRDM14 DCLK1 WWC1 | 2.93e-04 | 796 | 142 | 15 | PCBC_ratio_SC_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | NPR2 CUX2 TRIM2 MAP2 CENPE GLYCTK POU2F1 TRIM71 NCKAP5 MEOX2 NRXN3 ALMS1 OSGEPL1 AIF1 PLCH1 NMT1 WWC1 | 3.23e-04 | 986 | 142 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | NPR2 CUX2 TRIM2 ITGA8 LARP1 SUCLG2 MYORG MEOX2 LRIG3 NUDT11 NUDT10 MTHFD2L PLCH1 | 3.35e-04 | 633 | 142 | 13 | gudmap_kidney_P1_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | CUX2 TRIM2 ITGA8 LARP1 MYORG MEOX2 LRIG3 NUDT11 NUDT10 NEIL3 PLCH1 SLC25A19 DYRK3 | 3.51e-04 | 636 | 142 | 13 | gudmap_kidney_P2_CapMes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | HEXB ADAM19 GNE VAMP5 ASAH2 RPS6KA1 PRND ARMCX4 TEK MEOX2 AIF1 LYN CNN3 DYRK2 KLHL4 | 3.85e-04 | 817 | 142 | 15 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 4.28e-04 | 202 | 142 | 7 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | HSPD1 CENPE POLD1 ARHGAP11A NEK2 ALMS1 NEIL3 LTF KIF18B CNN3 | 4.38e-04 | 409 | 142 | 10 | GSM399452_500 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_500 | POLD1 TRMT1 MEOX2 LRIG3 IGF2BP1 RECQL4 CHEK2 IGSF9 PLCH1 SLC25A19 | 4.55e-04 | 411 | 142 | 10 | gudmap_developingKidney_e12.5_renal vesicle_500 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#1_top-relative-expression-ranked_1000 | SPOUT1 POLD1 TRMT1 LRIG3 IGF2BP1 PDRG1 RECQL4 CHEK2 IGSF9 DYRK3 | 4.64e-04 | 412 | 142 | 10 | gudmap_developingKidney_e12.5_renal vesicle_1000_k1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.67e-04 | 205 | 142 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_500 | 4.72e-04 | 339 | 142 | 9 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | HSPD1 CENPE ARHGAP11A NEK2 IGF2BP1 IGF2BP3 CHEK2 NEIL3 KIF18B CNN3 | 5.19e-04 | 418 | 142 | 10 | GSM538350_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | HSPD1 CENPE ARHGAP11A NEK2 IGF2BP1 IGF2BP3 CHEK2 NEIL3 KIF18B CNN3 | 5.59e-04 | 422 | 142 | 10 | GSM538357_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | HSPD1 CENPE ARHGAP11A NEK2 IGF2BP1 IGF2BP3 CHEK2 NEIL3 KIF18B CNN3 | 5.59e-04 | 422 | 142 | 10 | GSM538355_500 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL7A1 CENPE ARHGAP11A NEK2 RECQL4 CHEK2 NEIL3 KIF18B IQGAP3 | 1.87e-08 | 198 | 145 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-07 | 178 | 145 | 8 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-07 | 182 | 145 | 8 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-07 | 182 | 145 | 8 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 186 | 145 | 8 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 186 | 145 | 8 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 187 | 145 | 8 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-07 | 191 | 145 | 8 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.21e-07 | 191 | 145 | 8 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-07 | 129 | 145 | 7 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 2.49e-07 | 194 | 145 | 8 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.79e-07 | 197 | 145 | 8 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.79e-07 | 197 | 145 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.79e-07 | 197 | 145 | 8 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-07 | 199 | 145 | 8 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.02e-07 | 199 | 145 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.02e-07 | 199 | 145 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-07 | 200 | 145 | 8 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.79e-07 | 155 | 145 | 7 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 163 | 145 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-06 | 166 | 145 | 7 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 169 | 145 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 171 | 145 | 7 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 171 | 145 | 7 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 171 | 145 | 7 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 172 | 145 | 7 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 173 | 145 | 7 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 173 | 145 | 7 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 173 | 145 | 7 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 173 | 145 | 7 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 174 | 145 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 174 | 145 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 175 | 145 | 7 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 177 | 145 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 177 | 145 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 178 | 145 | 7 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 179 | 145 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 181 | 145 | 7 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 181 | 145 | 7 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 2.36e-06 | 183 | 145 | 7 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-06 | 183 | 145 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 187 | 145 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 189 | 145 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 191 | 145 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 192 | 145 | 7 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 192 | 145 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 192 | 145 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.24e-06 | 192 | 145 | 7 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 192 | 145 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 3.24e-06 | 192 | 145 | 7 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 3.36e-06 | 193 | 145 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.47e-06 | 194 | 145 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.47e-06 | 194 | 145 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 194 | 145 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.47e-06 | 194 | 145 | 7 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.47e-06 | 194 | 145 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.59e-06 | 195 | 145 | 7 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.59e-06 | 195 | 145 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.59e-06 | 195 | 145 | 7 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.59e-06 | 195 | 145 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-06 | 196 | 145 | 7 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.72e-06 | 196 | 145 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.72e-06 | 196 | 145 | 7 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-06 | 196 | 145 | 7 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-06 | 196 | 145 | 7 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.72e-06 | 196 | 145 | 7 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.72e-06 | 196 | 145 | 7 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.72e-06 | 196 | 145 | 7 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.72e-06 | 196 | 145 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-06 | 196 | 145 | 7 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.72e-06 | 196 | 145 | 7 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.84e-06 | 197 | 145 | 7 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-06 | 197 | 145 | 7 | 954d4deaeba50c5b3faf52105c4cde961a682be1 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 3.84e-06 | 197 | 145 | 7 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.84e-06 | 197 | 145 | 7 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.84e-06 | 197 | 145 | 7 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 3.97e-06 | 198 | 145 | 7 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.97e-06 | 198 | 145 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.97e-06 | 198 | 145 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.97e-06 | 198 | 145 | 7 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 3.97e-06 | 198 | 145 | 7 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 3.97e-06 | 198 | 145 | 7 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-06 | 198 | 145 | 7 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-06 | 198 | 145 | 7 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 3.97e-06 | 198 | 145 | 7 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 4.11e-06 | 199 | 145 | 7 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 4.11e-06 | 199 | 145 | 7 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.11e-06 | 199 | 145 | 7 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 4.11e-06 | 199 | 145 | 7 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 4.11e-06 | 199 | 145 | 7 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | 99437f8b57d168c550ccfd1fbda5454c26f971a8 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.11e-06 | 199 | 145 | 7 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 4.11e-06 | 199 | 145 | 7 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | 13ff6c26ebcc663ef8e5559ab9be99dab848abe7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 4.11e-06 | 199 | 145 | 7 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.11e-06 | 199 | 145 | 7 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | f0944961f99c600ad5fa588b19321fce991258f7 | |
| Computational | Response to DNA damage. | 3.09e-06 | 187 | 89 | 10 | MODULE_244 | |
| Disease | immune system disease (implicated_via_orthology) | 6.21e-05 | 3 | 135 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | Liver carcinoma | ACACA CENPE ARHGAP11A DNAJC6 NEK2 IGF2BP1 IGF2BP3 NEIL3 KIF18B IQGAP3 | 1.19e-04 | 507 | 135 | 10 | C2239176 |
| Disease | acquired metabolic disease (implicated_via_orthology) | 1.24e-04 | 4 | 135 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | response to cranial radiation therapy, short-term memory | 1.68e-04 | 60 | 135 | 4 | EFO_0004335, EFO_0010950 | |
| Disease | estrogen measurement, response to aromatase inhibitor | 2.06e-04 | 5 | 135 | 2 | EFO_0011007, GO_0061477 | |
| Disease | muscular disease (implicated_via_orthology) | 2.06e-04 | 5 | 135 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | health study participation | 2.86e-04 | 195 | 135 | 6 | EFO_0010130 | |
| Disease | brain volume measurement, putamen volume | 3.08e-04 | 6 | 135 | 2 | EFO_0006930, EFO_0006932 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.60e-04 | 286 | 135 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 4.30e-04 | 7 | 135 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | NPR2 NAT9 ASAH2 SPTA1 TRMT1 LARP1 MIDEAS ANKRD27 ATP6AP1L ESYT3 NEK2 SLC34A1 CHEK2 AFDN LYN NMT1 | 4.52e-04 | 1347 | 135 | 16 | EFO_0005192 |
| Disease | juvenile rheumatoid arthritis (is_marker_for) | 5.71e-04 | 8 | 135 | 2 | DOID:676 (is_marker_for) | |
| Disease | susceptibility to influenza measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0803537 | |
| Disease | Nephroblastoma | 9.13e-04 | 10 | 135 | 2 | Orphanet_654 | |
| Disease | hip geometry | 1.08e-03 | 44 | 135 | 3 | EFO_0004685 | |
| Disease | Premature Birth | 1.11e-03 | 11 | 135 | 2 | C0151526 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 1.11e-03 | 11 | 135 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.11e-03 | 11 | 135 | 2 | C1335302 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.26e-03 | 102 | 135 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | neuroimaging measurement | HSPD1 MPP2 MAP2 MBL2 NCKAP5 ATP6AP1L IGF2BP1 DLG2 IGSF9 KIF18B PLCH1 DCLK1 WWC1 | 1.28e-03 | 1069 | 135 | 13 | EFO_0004346 |
| Disease | survival time, lung adenocarcinoma | 1.33e-03 | 12 | 135 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | schizophrenia, anorexia nervosa | 1.39e-03 | 48 | 135 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.48e-03 | 49 | 135 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.48e-03 | 49 | 135 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.50e-03 | 268 | 135 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Modic type vertebral endplate changes | 1.57e-03 | 13 | 135 | 2 | HP_0030775 | |
| Disease | neutrophil count | CUX2 ADAM19 POU2F1 CHD9 IGF2BP3 SNX32 SBF2 RRP12 CHEK2 MTHFD2L LYN STK38L TAP2 HSPA7 ATP6V0A2 | 1.68e-03 | 1382 | 135 | 15 | EFO_0004833 |
| Disease | idiopathic osteonecrosis of the femoral head | 1.76e-03 | 52 | 135 | 3 | EFO_1001930 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.10e-03 | 15 | 135 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | N-acetylarginine measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0021429 | |
| Disease | triiodothyronine measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0008392 | |
| Disease | migraine without aura, susceptibility to, 4 | 2.39e-03 | 16 | 135 | 2 | MONDO_0011847 | |
| Disease | 1-Methylhistidine measurement | 2.70e-03 | 17 | 135 | 2 | EFO_0021543 | |
| Disease | fish consumption measurement | 3.18e-03 | 64 | 135 | 3 | EFO_0010139 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 3.47e-03 | 66 | 135 | 3 | EFO_0007708 | |
| Disease | number of teeth measurement | 3.74e-03 | 20 | 135 | 2 | EFO_0010073 | |
| Disease | insomnia measurement | 4.38e-03 | 443 | 135 | 7 | EFO_0007876 | |
| Disease | Lewy Body Disease | 4.52e-03 | 22 | 135 | 2 | C0752347 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKRLFGGQIVGQALV | 51 | O14734 | |
| SIVAAKGAGQDKLGI | 1021 | P55196 | |
| EQLAQKDNFLGLRGK | 316 | A0FGR9 | |
| AKLQAQVRIGGKGTA | 56 | P20290 | |
| DIGKKLGQNGLDNGF | 246 | O15254 | |
| GLQGGRCRVEKTKQF | 916 | Q9H013 | |
| LKGAQLSGGQKQRLA | 1151 | Q2M3G0 | |
| KELGSGQFGVVQLGK | 421 | P51813 | |
| GIQAGNLEIVNGAKK | 3886 | Q8TCU4 | |
| RFGGNKVIEKVLIAN | 111 | Q13085 | |
| NVDFRGKKVIELGAG | 71 | Q96AZ1 | |
| QIKGFIRRFNKEGGT | 781 | P20594 | |
| QVVAVKAPGFGDNRK | 296 | P10809 | |
| NGTFVNTELVGKGKR | 166 | O96017 | |
| KNGICQRIFGEKVLG | 911 | O14529 | |
| AGGAAGLFAKQVQKK | 6 | Q9UBW5 | |
| KKIQGGTEIQRGSFA | 76 | P0CE67 | |
| FQGEVLPGAKNKVRG | 956 | Q5H9R4 | |
| GVKGKLGRLLGVFEQ | 71 | Q8NFP7 | |
| RLFEAQGKPELKGFN | 101 | Q9NUG6 | |
| KDHVGRNNGNGLVKF | 336 | Q9NTZ6 | |
| ILAVDNFNGIKIKGR | 91 | Q9Y388 | |
| FQAQDISGRKKGRGV | 946 | Q99666 | |
| IDKLGQNIAVVGKFG | 501 | Q4ADV7 | |
| KDVFIQGNRIKLGAG | 71 | Q96NW4 | |
| GGKAIEHLAKQGNRF | 221 | Q9H4B0 | |
| QRKGSKVGDFGDAIN | 161 | Q6PKG0 | |
| VDLTKRFGNLKNGVN | 276 | P17612 | |
| GDGLKRALQGKVASF | 491 | Q2Q1W2 | |
| GLGINGKVLQIFNKR | 71 | P49137 | |
| FLEKLKFGIGDGNLQ | 461 | P30419 | |
| LRVVGKDGENKGRQF | 516 | Q8TAT5 | |
| GKQNVKLGDFGLARI | 151 | P51955 | |
| VAKTQKAEGGGRLQA | 506 | Q8IX03 | |
| GEGLGKIIQRFPQKD | 21 | Q86WG5 | |
| KIKNVDGLTFQGLGA | 226 | Q6UXM1 | |
| NFVGRLIGKEGRNLK | 286 | Q9NZI8 | |
| GKIFINKGNVDGVQI | 241 | Q9NR71 | |
| QRGLKTNNAAVFKVG | 2881 | Q2LD37 | |
| KVGRTIGDGNFAVVK | 391 | O15075 | |
| GGHERKVAQKLLNGQ | 66 | A6NF83 | |
| GRAAFGNIKNAIKPV | 241 | Q9Y2G0 | |
| AQIAIGGKDKGRLFQ | 1216 | Q9Y4C0 | |
| RELQGFLDGVKKGQE | 281 | Q8WX92 | |
| KQRRIKLGFTQGDVG | 211 | P09086 | |
| GKQVGNKFFLTNGEI | 131 | P11226 | |
| AFKGKRVLVIGLGNS | 181 | O60774 | |
| KGGQQGAAAREKELV | 246 | P50222 | |
| GVKGKLGRLLGVFEQ | 71 | Q96G61 | |
| GAQGVGRRSLKNKLI | 381 | Q14168 | |
| FELGGDKKRKGQVIQ | 91 | Q969Q0 | |
| AALRKKLQVYEGGGQ | 381 | Q86Y91 | |
| GAKLNFKEGLQRGIS | 896 | Q6NV74 | |
| VALNNKLYAIGGRDG | 566 | Q9C0H6 | |
| NFVGRLIGKEGRNLK | 286 | O00425 | |
| LGVAAINQAIKEGKA | 611 | Q86VI3 | |
| AGKDQRGKVLIYNGN | 411 | P53708 | |
| RGKVLIYNGNKDGLN | 416 | P53708 | |
| QRQATKDAGAIAGLK | 156 | P48741 | |
| KQRRIKLGFTQGDVG | 296 | P14859 | |
| QLAGGKVAGDIFKDN | 126 | Q06495 | |
| KGGNNKLIKVFHRDG | 371 | O00459 | |
| ARALGVRTENGKNKG | 411 | Q6PI47 | |
| FQLKFEGRVGKGQRG | 1436 | Q5VYJ5 | |
| DEGGLKLTFQKQGLA | 2351 | Q3L8U1 | |
| RKFGQGKGLENFVTL | 526 | Q9Y223 | |
| RKALSQLKGGGLAQA | 216 | Q8IVS8 | |
| GLDKAVLQDINRKGG | 926 | Q8TD26 | |
| LRNKGITIFAVGVGK | 941 | A8TX70 | |
| VKGGAGRLFSNLKDN | 26 | O75061 | |
| LINKAQGSKLVIGGA | 476 | P36269 | |
| LGIAKGLGKDNQRSF | 196 | Q9NTJ4 | |
| SIKLVKRLGAGQFGE | 246 | P07948 | |
| KQVKIGRNGTLTFGD | 876 | Q6PJG2 | |
| VDLNFGGLQGRGVKK | 121 | P59910 | |
| LEEFRKNLKGVNGGK | 851 | Q92538 | |
| QRLKGQGVKLFAVGI | 161 | Q02388 | |
| KIIDGGAAQKDGRLQ | 226 | Q15700 | |
| ESVLRGKFAAGKNGL | 31 | Q8WYP5 | |
| KLGKVEFSGVRGNAL | 461 | Q9NYC9 | |
| FGGTQKQKQLFIGGE | 471 | P07686 | |
| TGKVGGLLAFAKRRN | 996 | P28340 | |
| LKQQGRSGIKVIDFG | 356 | Q92630 | |
| GQKLGLSNGGQVFLK | 81 | O43933 | |
| GRAIYLLKVGKAGQN | 151 | P15086 | |
| GQVIKKLSDGQVGGF | 266 | Q02224 | |
| VLKIIGKGSFGQVAR | 211 | O43781 | |
| LQRGKKQQIENGSGA | 156 | Q99496 | |
| GVGKKGQACVQLARI | 131 | Q5T280 | |
| GNVKLGDFGASKRLQ | 501 | Q99759 | |
| DFNKQVTLGRGGQIL | 546 | Q3ZCN5 | |
| LGRVGKVVKVFGDGN | 361 | Q96AX9 | |
| KGSFVGNIAKDLGLQ | 41 | Q9Y5H4 | |
| LKAAAGIEKGARQTG | 91 | Q9Y3B7 | |
| AAKAKAVGIQGNLSG | 126 | Q8TBF2 | |
| RLKFNLGKNGREVNG | 436 | Q6P4F7 | |
| GRGAFGEVRLVQKKD | 96 | Q15208 | |
| EFARIQLGAKGIQIK | 91 | Q9NXH9 | |
| RIRSNGKFGGLQNKA | 1866 | A6NHR9 | |
| IGRGAFGEVRLVQKK | 96 | Q9Y2H1 | |
| GGUQLNRLKEVKAFV | 46 | Q8WWX9 | |
| KGVRFGPFQGKVVNA | 276 | Q9GZV8 | |
| VVKKGGSFQLNELQG | 116 | P02788 | |
| NLGLKGREGRAKVVN | 731 | O15061 | |
| NGFGAGRGQLVKALK | 1886 | O14513 | |
| FELGGDKKRKGQVIQ | 91 | P83881 | |
| GQRLKANLKGTLQAG | 106 | O94761 | |
| AQIAIGGKDKGRLFQ | 211 | Q9HDB5 | |
| LEVRGVKGVFLANQK | 446 | Q96PQ0 | |
| ELYLNEKKRGAAGGN | 911 | O75182 | |
| LGKGNFAVVKLGRHR | 26 | Q9H0K1 | |
| GEKGSQLAAGQKQRL | 601 | Q03519 | |
| LKGKFLINLEGGDIR | 956 | Q9NSE4 | |
| GQFKGLVKAARRGSQ | 1271 | Q5JTH9 | |
| DLQGGKAFGLLKAQQ | 6 | P55008 | |
| RFDEGKLKAGQSVIG | 151 | Q15417 | |
| AGIAAAARAKQKGVI | 131 | P82912 | |
| VLKAQILAGGRGKGV | 81 | Q96I99 | |
| QGGQAVAIGQFKDRI | 76 | Q86XK7 | |
| QGTVRKAGALAVKNF | 431 | Q13009 | |
| GKDFAGIQVGKLADL | 536 | Q9BW04 | |
| KGLALQRQGKLFGAA | 241 | Q13813 | |
| VAENRPGAFIKQGRK | 51 | Q9UKY0 | |
| KFSLKLNGGRHVQGI | 16 | A8MWD9 | |
| RNNFGKVLERGVKLA | 21 | O95183 | |
| GKGLAEVQNRLRKHG | 716 | P02549 | |
| GEGNFGQVLKARIKK | 831 | Q02763 | |
| KLRGKDLGQGQGQVQ | 171 | Q9P2J2 | |
| FLGATKNRQLQGLKG | 876 | Q4KWH8 | |
| FGKNVVVAGRSKNVG | 206 | Q9H903 | |
| GGGNVKIDSQKLNFR | 1751 | P11137 | |
| IRAAKGLDQALKEGG | 91 | Q96GY0 | |
| GKLKERVGNSAGQSL | 141 | Q9BRH9 | |
| NKFGELGGFAAIQAK | 286 | Q9UPU5 | |
| GKGFIQKGNLLIHRR | 406 | Q6PF04 | |
| QKAVDKGQGAQRLEG | 136 | P52746 | |
| VGTKGRNKGEFTNLQ | 476 | Q9C040 | |
| AVNGISKGIIKQFLG | 121 | Q9H9Y6 | |
| GNQGVGKNKIVDRFL | 781 | A3KMH1 | |
| GKNRKELLGGFLRNI | 171 | Q86XE0 | |
| QVLQKEGALGFFKGL | 271 | Q9HC21 | |
| QGFAIKGGRFTKAQD | 126 | Q52LC2 | |
| LKIAEVGAGGNKSRL | 86 | Q00577 | |
| DGIINAKIKNVALGG | 331 | Q96GX1 | |
| LQGFDGKIVAQGKLL | 2151 | O75962 | |
| AKLGFVSGLINQGKV | 171 | Q9Y487 | |
| KVLGQGSFGKVFLVR | 66 | Q15418 | |
| LGLTKFEAKIGQGNE | 136 | Q9BTE0 | |
| KAGGFSIRNQKGEQV | 96 | Q6NSJ0 |